Turn demo interest into a paid pilot path
Tell us what you want to solve. SCRIMED maps the right demo to the right pilot package.
Use this accelerator to choose a demo, see the recommended pilot, understand the price band, gather proof assets, and start no-PHI intake without drifting into custom scope too early.
Simple buying rule
Free public demos prove the product. Paid assessments and pilots begin when SCRIMED starts doing buyer-specific work.
SCRIMED Pilot Demo Commercial Readiness turns demos, pilot programs, pricing tiers, market benchmarks, proof routes, onboarding steps, and margin controls into a seamless no-PHI buyer path. It is commercial readiness and pricing guidance only. It does not create a signed quote, contract, legal advice, accounting advice, tax advice, audited financial reporting, securities material, investment advice, valuation assurance, revenue guarantee, profit guarantee, ROI guarantee, reimbursement guarantee, customer permission, procurement approval, security certification, PHI processing authority, production connector approval, EHR writeback approval, payer submission approval, or live clinical care authorization.
01Choose the buyer problem: Free public preview; no custom work starts here.02Run the proof path: Guided demo is free for qualified buyers; custom demo prep becomes paid diligence.03Match the pilot package: Package price band is shown before custom SOW expansion.04Submit no-PHI intake: No unpaid implementation or security questionnaire work before package selection.05Open buyer deal room: Paid diligence or activation retainer protects margin before enterprise proof work expands.06Kick off scoped delivery: Implementation, connectors, support, and review retainers stay separate from license fees.
Demo to pilot paths
Each demo now has a recommended package, price band, proof list, and no-PHI intake path.
Synthetic Pilot Evaluation
CarePath Access Operations Demo
Access, care navigation, discharge, population health, and throughput leaders.
$125k-$350k for 45-90 days after sponsor and workflow owner are confirmed.
- Pilot: 60-Day Governed Automation Pilot
- Proof: /workflows/results/carepath-high-risk-followup-routing, /modules/carepath-ai, /synthetic/validation
- No autonomous outreach, diagnosis, treatment, emergency routing, PHI, or live workflow execution.
Synthetic Pilot Evaluation
DocuTwin Documentation Review Demo
Clinical documentation, ambulatory operations, quality, and CMIO teams.
$125k-$350k standard; custom note-quality, source-trace, or specialty packet work priced separately.
- Pilot: 60-Day Governed Automation Pilot
- Proof: /workflows/results/docutwin-draft-note-review, /modules/docutwin, /evaluation
- No final note, EHR filing, diagnosis insertion, autonomous documentation, PHI, or clinical validation claim.
Synthetic Pilot Evaluation
PayerIQ Documentation Readiness Demo
Prior authorization, RCM, utilization-management, access, and finance transformation leaders.
$125k-$350k for a governed synthetic documentation-readiness pilot; buyer-specific policy mapping is separately scoped.
- Pilot: 60-Day Governed Automation Pilot
- Proof: /documentation-before-authorization, /healthcare-value-realization, /health-records
- No live PHI, medical-necessity determination, payer submission, appeal filing, EHR writeback, or reimbursement guarantee.
Synthetic Pilot Evaluation
TrialCore Research Operations Demo
Research operations, oncology programs, academic medical centers, and trial networks.
$125k-$350k standard; research-network or multi-study scope requires custom pricing.
- Pilot: 60-Day Governed Automation Pilot
- Proof: /workflows/results/trialcore-eligibility-review-queue, /modules/trialcore, /workflows/results/validation
- No patient outreach, enrollment decision, treatment recommendation, PHI, or production research-record mutation.
Interoperability Readiness Sprint
Atlas Interoperability Readiness Demo
CIOs, integration leaders, EHR teams, health tech platforms, and security teams.
$75k-$225k for readiness; production connector work requires separate reviewed scope.
- Pilot: AI Governance + Interoperability Readiness Pilot
- Proof: /interoperability/evaluations, /interoperability/evaluations/fhir-r4-us-core-intake, /health-records
- No live healthcare data exchange, connector certification, trading-partner acceptance, or production mutation.
TrustOS AI Governance Audit
AgentOS Governance Evaluation Demo
AI governance, compliance, innovation, clinical transformation, and executive leaders.
$75k-$225k for governance and interoperability readiness; protected pilot scope starts above this.
- Pilot: AI Governance + Interoperability Readiness Pilot
- Proof: /agents, /audit, /trust
- No live PHI ingestion, autonomous clinical execution, production connector access, or payer/patient action.
Buyer conversion packets
Every demo ends with one sponsor, one owner, one proof bundle, one paid step, and one retained boundary.
Synthetic Pilot Evaluation
CarePath Access Operations Demo
Confirm one access workflow, sponsor, reviewer role, price band, and no-PHI intake before opening scoped pilot work.
$125k-$350k for 45-90 days after sponsor and workflow owner are confirmed.
- Sponsor: VP Access, Chief Operating Officer, or Population Health leader
- Owner: Access operations manager or care coordination director
- Cadence: Weekly workflow review with synthetic queue metrics and escalation notes
- Decision window: Two buyer meetings after the no-PHI demo
- Acceptance: Buyer names a workflow owner and reviewer role. Synthetic queue or routing fixture is accepted as the pilot input boundary.
- Paid trigger: Buyer asks for site-specific workflow mapping.
- Disqualifier: Buyer wants live patient routing before clinical authority approval.
- Human review: true
- Audit hash: scrimed-intel-fcbde5ee
Synthetic Pilot Evaluation
DocuTwin Documentation Review Demo
Convert the buyer to a governed documentation pilot with capped note fixtures, reviewer role, and source-trace acceptance criteria.
$125k-$350k standard; custom note-quality, source-trace, or specialty packet work priced separately.
- Sponsor: CMIO, documentation improvement leader, ambulatory operations leader, or quality executive
- Owner: Clinical documentation manager or physician champion
- Cadence: Weekly note-quality review with source-trace and missing-context findings
- Decision window: One demo review plus one packet-scoping call
- Acceptance: Buyer agrees final note signature and EHR filing remain out of scope. Synthetic note fixtures and source traces are accepted for the pilot.
- Paid trigger: Buyer asks for specialty-specific note packets.
- Disqualifier: Buyer wants autonomous chart filing.
- Human review: true
- Audit hash: scrimed-intel-9154add2
Synthetic Pilot Evaluation
PayerIQ Documentation Readiness Demo
Scope one procedure family, synthetic requirement set, reviewer role, buyer baseline, price band, and no-submission acceptance criteria.
$125k-$350k for a governed synthetic documentation-readiness pilot; buyer-specific policy mapping is separately scoped.
- Sponsor: VP Revenue Cycle, prior authorization director, utilization-management leader, or CFO transformation sponsor
- Owner: Prior authorization operations manager or RCM documentation lead
- Cadence: Weekly completeness and evidence-gap review with policy-source freshness, reviewer disposition, and no-submission proof
- Decision window: One workbench review plus one workflow and measurement scoping call
- Acceptance: Buyer accepts registered synthetic packets as the initial data boundary. Buyer names a prior-authorization workflow owner and qualified reviewer role.
- Paid trigger: Buyer asks for organization-specific policy requirement mapping.
- Disqualifier: Buyer wants autonomous payer submission or appeal filing.
- Human review: true
- Audit hash: scrimed-intel-6f774598
Synthetic Pilot Evaluation
TrialCore Research Operations Demo
Scope a research-operations pilot around criteria trace, reviewer queue, evidence gaps, and no-PHI fixtures.
$125k-$350k standard; research-network or multi-study scope requires custom pricing.
- Sponsor: Research operations leader, oncology program leader, or clinical trials executive
- Owner: Trial operations manager or protocol-review lead
- Cadence: Weekly criteria-gap review with reviewer signoff and evidence trace
- Decision window: Two research-operations scoping sessions after demo review
- Acceptance: Buyer agrees SCRIMED supports review queue operations only. Synthetic eligibility and protocol fixtures are accepted.
- Paid trigger: Buyer asks for multi-study mapping.
- Disqualifier: Buyer wants enrollment approval automation.
- Human review: true
- Audit hash: scrimed-intel-62c681ba
Interoperability Readiness Sprint
Atlas Interoperability Readiness Demo
Move to a standards-readiness sprint with one data-family target, proof route, owner, and connector-boundary memo.
$75k-$225k for readiness; production connector work requires separate reviewed scope.
- Sponsor: CIO, integration leader, digital health executive, or platform owner
- Owner: FHIR, HL7, or integration architecture lead
- Cadence: Biweekly standards-readiness review with proof routes and connector-boundary decisions
- Decision window: One technical scoping session after the demo
- Acceptance: Buyer agrees readiness does not equal production connector approval. Synthetic FHIR/HL7/DICOM metadata fixtures are used.
- Paid trigger: Buyer asks for source-system mapping.
- Disqualifier: Buyer wants live exchange before connector approval.
- Human review: true
- Audit hash: scrimed-intel-9c58c6b5
TrustOS AI Governance Audit
AgentOS Governance Evaluation Demo
Convert to a governance audit with inventory scope, policy stack, reviewer role, and no-production-authority boundary.
$75k-$225k for governance and interoperability readiness; protected pilot scope starts above this.
- Sponsor: Chief AI officer, compliance executive, innovation leader, or clinical transformation leader
- Owner: AI governance program owner or compliance reviewer
- Cadence: Weekly governance review with policy decisions, audit evidence, and blocked-action register
- Decision window: One governance demo plus one executive readiness review
- Acceptance: Buyer agrees the output is governance readiness, not production AI authorization. Synthetic agent actions and policy decisions are used.
- Paid trigger: Buyer asks for AI inventory mapping.
- Disqualifier: Buyer wants autonomous clinical agent approval.
- Human review: true
- Audit hash: scrimed-intel-dc835f43
Market-aligned pricing
SCRIMED should be easy to try, but priced as enterprise healthcare intelligence infrastructure.
tier
Public Product Preview
Free, self-guided, no-PHI, no account required; qualified guided demo stays no-cost when it is standard.
Freed, Tali, and Heidi show that healthcare AI buyers expect a low-friction entry path before enterprise review.
- Keep standard demo labor capped; move custom demo prep, questionnaires, and buyer-specific proof packets into paid diligence.
- Use public demos to reduce buyer uncertainty, then ask for paid scope only when SCRIMED starts doing buyer-specific work.
- Risk avoided: Free preview could look like a full product trial if the next action is unclear.
tier
Workflow Intelligence Assessment
$25k-$75k standard; $12.5k-$25k mission clinic access path for one no-PHI workflow; $75k-$150k for multi-workflow enterprise assessment.
Individual scribe subscriptions are cheap, but enterprise assessment value sits in workflow redesign, governance, interoperability, and executive decision support.
- Cap workflows, meetings, artifacts, and review cycles; discount only by reducing scope.
- A fast, finite way to decide whether a full pilot is worth funding.
- Risk avoided: Too-low sprint pricing can underprice founder/product time and create bespoke consulting drag.
tier
Synthetic Pilot Evaluation
$125k-$350k standard for 45-90 days; $350k-$500k when multiple workflows, extra diligence, or executive proof packets are included.
Enterprise AI workflow pilots should sit well above seat-based scribe tools while staying below production integration commitments.
- Limit workflow count and evidence cadence; separately price custom data modeling, legal/security packet labor, and implementation planning.
- A decision-grade enterprise evaluation before the buyer funds protected production work.
- Risk avoided: Old ranges diverged across pricing and pilot pages, confusing buyers and weakening deal discipline.
tier
Protected Enterprise Pilot
$400k-$1.25M for 90-180 days; $1.25M-$2M+ when buyer-specific protected diligence, sandbox planning, or multi-site scope expands.
Redox and enterprise AI vendors use custom pricing because integration, security, governance, reliability, and implementation scope drive cost.
- Separate license, services, support, connectors, evidence-room labor, customer success, and change orders.
- A controlled enterprise activation path that prepares production without pretending production is already approved.
- Risk avoided: Low protected-pilot ranges can ignore security, privacy, evidence-room, tenant, connector, and support costs.
tier
Enterprise Operating License
$1.5M-$6M annual for initial enterprise operating layer; $6M-$12M+ for multi-department or multi-region expansion.
Ambience, Suki, Redox, and similar enterprise motions compete on workflow breadth, EHR adjacency, trust, uptime, data exchange, and measurable operational outcomes.
- Annual license is separate from implementation services, model usage, support tier, connector work, and continuous review retainer.
- Start with validated workflows, then expand as evidence, authority, and operational coverage mature.
- Risk avoided: A single giant range can feel arbitrary before pilots prove value.
tier
Strategic Platform Partnership
$8M-$25M+ multi-year, sales-led, region-aware, and external-review-gated.
National, payer, sovereign, and platform partnerships are not scribe subscriptions; they are multi-stakeholder infrastructure and governance programs.
- Regional legal, tax, hosting, support, partner economics, and certification work require separate review.
- Strategic partnership follows proven pilot evidence and clear authority boundaries.
- Risk avoided: Strategic pricing can overpromise national or global deployment before regional authority exists.
Market context
Use competitor pricing as context, not as SCRIMED's ceiling.
Freed
Individual clinician plans publicly start at $39/month, Core is $79/month, Premier is $104/month, and Groups are custom.
- Do not price SCRIMED like a single-seat scribe; use those prices as a floor for narrow clinician utility and keep SCRIMED positioned around enterprise governance, workflow proof, interoperability, and buyer diligence.
- https://www.getfreed.ai/pricing
Tali
Free tier, paid clinician tiers around CA $50 to CA $150/month, and enterprise custom pricing for multi-clinician organizations.
- Keep public demos free and frictionless, but route organization-level proof, analytics, custom packets, governance, and onboarding into paid assessment or pilot scope.
- https://tali.ai/pricing
Heidi Health
Public plan architecture includes Free, Evidence Plus, Clinician, and Practice plans with team, EHR integration, SSO, service availability, and custom hosting features in higher tiers.
- SCRIMED should preserve a free public product preview while making enterprise controls, evidence rooms, and protected work explicitly sales-led.
- https://www.heidihealth.com/pricing
Suki
Enterprise-oriented pricing is sales-led; public product copy spans pre-visit, encounter, post-visit, EHR delivery, order staging, coding, and multilingual instructions.
- SCRIMED should price pilots by workflow family, governance burden, proof depth, and connector/readiness complexity rather than by seat alone.
- https://www.suki.ai/clinicians/
Ambience Healthcare
Sales-led enterprise motion with published outcome claims around utilization, charting time, coding, EHR integration, and revenue integrity.
- SCRIMED can command enterprise pricing only when claims stay evidence-backed, buyer-permitted, and scoped to no-PHI pilots until clinical production gates are complete.
- https://www.ambiencehealthcare.com/
Redox
Custom pricing for healthcare integration needs, with scale signals around transactions, connected organizations, uptime, EHR connections, HITRUST, and SOC 2.
- Keep SCRIMED connector, data exchange, and production integration work out of standard pilot fees until separately reviewed and priced.
- https://redoxengine.com/
Berta open-source scribe deployment
The 2026 arXiv paper reports commercial AI scribes at $99-$600 per physician per month and an internal operating-cost benchmark below $30 per physician per month.
- SCRIMED must defend price through enterprise operating value: proof, governance, workflow redesign, interoperability readiness, safety controls, and margin-transparent implementation.
- https://arxiv.org/abs/2603.23513
Operator routine
Demo calls now have a short operating routine and clear hard stops.
Run before every buyer call
- Make /pilot-demo-commercial-readiness the internal and buyer-safe command page before demos or pilot calls.
- Start every buyer call with the closest demo path and end with one recommended package, price band, proof asset list, and no-PHI intake route.
- Use updated ranges as floors unless finance, legal, and founder review approve scope reduction.
- Route any custom proof, questionnaire, security review, or executive packet work into paid diligence or Enterprise Proof and Deal Room Activation.
- Keep enterprise license pricing separate from services, connectors, support, usage, and continuous review retainers.
Protect price, safety, and trust
- Do not accept PHI, patient identifiers, payer member identifiers, production credentials, secrets, or live records in demo or pilot intake.
- Do not quote custom SOWs, implementation work, connector work, security questionnaire labor, or evidence-room release without package selection and human deal review.
- Do not benchmark SCRIMED against low monthly AI-scribe seats as if SCRIMED were only documentation automation.
- Do not imply guaranteed ROI, revenue lift, reimbursement, clinical outcome improvement, customer permission, certification, production readiness, or legal approval.
- Do not open protected workspace evidence externally without AAL2 controls, release decision, recipient rules, and customer permission path.
Keep the path one click deep
- /demos
- /pilots
- /pricing
- /offerings
- /service-delivery
- /client-onboarding
- /pilot-deal-room
- /scrimed-execution-focus
- /scrimed-proof-packet-studio
- /clinical-production-readiness